NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease

American Journal of Gastroenterology

Volumn 99, Issue 6, 2004, Pages 1134-1140

  Karban, Amir ^a   Waterman, Matti ^b   Panhuysen, Carolien I ^b   Pollak, Rivka Dresner ^b   Nesher, Shula ^b   Datta, Lisa ^b   Weiss, Batia ^b   Suissa, Alain ^b   Shamir, Raanan ^b   Brant, Steven R ^b   Eliakim, Rami ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARD15 GENE; CAUCASIAN; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; FAMILY HISTORY; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; INCIDENCE; JEW; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NOD2 GENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION MAPPING; SMOKING; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; BASE SEQUENCE; CARRIER PROTEINS; CASE-CONTROL STUDIES; COHORT STUDIES; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISRAEL; JEWS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MONTE CARLO METHOD; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROBABILITY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VARIATION (GENETICS);

EID: 3142750001     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.04156.x     Document Type: Article

References (35)

1. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003;124:521-36.
2. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in Nod2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
3. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
4. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001;357:1925-8.
5. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86-91.
6. Leong RW, Armuzzi A, Ahmad T, et al. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther 2003;17:1465-70.
7. Yang H, McElree C, Roth MP, et al. Familial empiric risks for inflammatory bowel disease: Difference between Jews and non-Jews. Gut 1993;34:517-24.
8. Polito JM, Childs B, Mellits ED, et al. Crohn's disease: Influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996;111:580-6.
9. Bonen DK, Ogura Y, Nicolae DL, et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003;124:140-6.
10. Zhou Z, Lin X, Akolkar PN, et al. Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population. Am J Gastroenterol 2002;97:3095-3101.
11. Amar A, Kwon OJ, Motro U, et al. Molecular analysis of HLA class II polymorphisms among different ethnic groups in Israel. Hum Immunol 1999;60:723-30.
12. Kraviec J, Odes HS, Lasry Y, et al. Aspects of the epidemiology of Crohn's disease in the Jewish population in Beer Sheva, Israel. Isr J Med Sci 1984;20:16-21.
13. Fireman Z, Grossman A, Lilos P, et al. Epidemiology of Crohn's disease in the Jewish population of central Israel, 1970-1980. Am J Gastroenterol 1989;84:255-8.
14. Niv Y. The prevalence of Crohn's disease in the Israeli Kibbutz population. Can J Gastroenterol 1991;5:91-3.
15. Shapira M, Tamir A. Crohn's disease in the Kinneret subdistrict, Israel, 1960-1990. Incidence and prevalence in different ethnic subgroups. Eur J Epidemiol 1994;10:231-3.
16. Odes HS, Locker C, Neumann L, et al. Epidemiology of Crohn's disease in southern Israel. Am J Gastroenterol 1994;89:1859-62.
17. Niv Y, Abuksis G, Fraser GM. Epidemiology of Crohn's disease in Israel: A survey of Israeli Kibbutz settlements. Am J Gastroenterol 1999;94:2961-5.
18. Podolsky DK. Inflammatory bowel disease (1). N Engl J Med 1991;325:928-37.
19. Podolsky DK. Inflammatory bowel disease (2). N Engl J Med 1991;325:1008-16.
20. Gasche C, Schomerich J, Brynskov J, et al. A simple classification of Crohn's disease: Report of the Working Party for the World Congress of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
21. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
22. Zhao JH, Curtis D, Sham PC. Model-free analysis and permutation test for allelic associations. Hum Hered 2000;50:133-9.
23. Xie X, Ott J. Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet 1993;53:1107.
24. Sugimura K, Taylor KD, Lin Y, et al. A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet 2003;72:509-518.
25. Goldstein DB, Reich DE, Bradman N, et al. Age estimates of two common mutations causing factor XI deficiency: Recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews. Am J Hum Genet 1999;64:1071-5.
26. Karban A, Eliakim R. Failure to replicate the association of the novel NOD2/CARD15 haplotype (S268P-JW1) to Crohn's disease in the Jewish Israeli population Gastroenterology 2004;126:624-5.
27. Lindberg E, Jarnerot G, Huitfeldt B. Smoking in Crohn's disease: Effect on localization and clinical course. Gut 1992;33:779-82.
28. Brant SR, Picco MF, Achkar JP, et al. Defining complex contributions of Nod2/Card 15 gene mutations, age at onset and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis 2003;9:281-9.
29. Fidder HH, Avidan B, Lahav M, et al. Clinical and demographic characterization of Jewish Crohn's disease patients in Israel. Clin Gastroenterol 2003;36:8-12.
30. Zlotogora J, Zimmerman J, Rachmilewitz D. Prevalence of inflammatory bowel disease in family members of Jewish Crohn's disease patients in Israel. Dig Dis Sci 1991;36:471-75.
31. Van Der Paardt M, Crusius JB, De Koning MH, et al. CARD15 gene mutations are not associated with ankylosing spondylitis. Genes Immun 2003;4:77-8.
32. Orchard TR, Chua CN, Ahmad T, et al. Uveitis and erythema nodosum in inflamatory bowel diseases: Clinical features and the role of HLA genes. Gastroenterology 2002;123:714-18.
33. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002;122:854-66.
34. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-74.
35. Vermeire S, Wild G, Kocher K, et al. CARD15-genetic variation in a Quebec population: Prevalence, genotype-phenotype relationship and haplotype structure. Am J Hum Genet 2002;71:74-83.